Fortunis Capital Investee Clementine - sign a deal with Boots No.7.
Fortunis Capital Investee Clementine - the UK’s leading female focussed hypnotherapy app have signed a deal with Boots No.7.
A first in the industry, this exciting new partnership seeks to disrupt the multi billion pound health and beauty sector.
The new initiative tackles the global menopause market (with a size valued at USD 15.4 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.29% from 2022 to 2030) by producing a series of mind powered rituals matched with dedicated No.7 products to produce proven results - with 71% of users stating “after doing the ritual their skin has never felt better” and 89% stating “they felt more positive about the day ahead” .
“We are beyond excited to partner with the UK’s No 1 skincare brand to create a disrup;ve new way for women to engage with skincare in a way that will truly leave them feeling beAer in themselves”, says Kim Palmer, founder of Clementine.
“We’ve been working with No7 since Nov 2020 when we pitched an idea on how we could help women take self care off their to do lists. An idea that would bring together two very different worlds - skincare and therapy. An idea that would make looking aMer their mindset a daily ritual not a daily chore. Would make it so easy for women to actually enjoy doing this and not just endure.”
“As a female-led team, we want to partner with brands to further our mission ‘to create a world where every woman believes she can do anything she puts her mind to’. To do that, we need to take self-care off to-do lists and build it into the products and services that women consume every day.
“We’re excited to be building new skincare solu;ons and experiences that will have a las;ng impact on women’s skin, and their confidence.”
Not only is Clementine partnering with B2B’s to offer physical benefits to users, it is now positioning itself as a leading player in brand wellness consultancy - an area that is often over looked in corporate institutions.
Alongside the No.7 contract, Clementine has recently been revealed as one of “The Health Tech World Top 50 Innovators of 2022” (https://www.htworld.co.uk/.../health-tech-world-top-top.../) and has been selected by Glaxo Smith Kline - the Global Biopharma to work within their wellness Innovation programme. Clementine has also partnered with Buggaboo - a leading UK push chair retailer to create the industry’s first “mind powered walking club”, and the App has recently achieved ORCHA approval for use in the NHS.
A huge congratulations to Kim & her team!